Latest news with #Caliendo
CNBC
9 hours ago
- Business
- CNBC
UBS upgrades CVS to buy rating, sees further recovery ahead
UBS sees a rosy outlook ahead for CVS . The bank upgraded the pharmacy stock to a buy rating from neutral, with analyst Kevin Caliendo lifting his price target by 18%, to $79 from $67. Shares of CVS Health have already surged 53% this year, through Friday's close. Caliendo's updated target implies an additional 15% upside ahead for the stock. CVS YTD mountain CVS YTD chart "Despite the YTD improvement in shares, we continue to see incremental upside, both from a long-term EPS perspective, with multiple years of [double-digit] earnings growth ahead given multiple pathways (but primarily hinging on the [healthcare benefits] recovery), and from a valuation multiple perspective," the analyst wrote. "While it remains early in the tenure of the new management team, stability in messaging and continued momentum in HCB earnings improvement (especially in light of peers' challenges) provides us with enough conviction today to make a call on the stock." Caliendo noted that his upgrade follows two strong consecutive quarters for CVS that indicate fixes to its healthcare benefits segment are on track. "Critically, the benefit cuts and assumptions CVS made around Medicare Advantage (MA) utilization this current plan year have proved to be on-point (meaningful prior year development provides comfort), giving us more conviction in the company's ability to forecast and manage trend," he added. "This is especially relevant as the company manages to [reprice] a disproportionate share of multi-year contracts in its group MA business (~50%) this year, which we believe are performing at a negative [mid-single digit] to [high-single digit] margin today." Caliendo sees CVS earning $7.20 per share by the end of fiscal year 2026, up from a prior estimate of $6.92 and a Wall Street consensus of $7.15. The healthcare benefit and pharmacy chain is likely to see 14% compound annual growth in its earnings per share through 2028 — whereas the Street only sees 12% — yet sells at a multiple of 9 times estimated 2026 results, versus a 10-year average of 10 times, the UBS analysts said.
USA Today
24-06-2025
- Sport
- USA Today
Kansas City Chiefs OL shouldn't be counted out for a potential starting role
The results of Super Bowl LIX are fresh in the minds of all the Kansas City Chiefs players involved, especially on the offensive line. Mike Caliendo stepped into a starter's role following the position change of Joe Thuney late last season and could see a redemption season in 2025 after a promising offseason. "He's (Mike Caliendo) had a great one. (He's) a great kid – very, very smart. (He's) a hard worker, (and) he's gotten better every year," said head coach Andy Reid during his minicamp press conference, "For him to step in and do what he did this past year, he knows he can play at this level. We saw how (Commanders G Nick) Allegretti did it, and I'd tell you that he's doing the same. He looks like the building blocks are kind of the same there." Caliendo has been complimentary of projected starter Kingsley Suamataia throughout OTAs, as he will be competing for playing time in training camp alongside many other position groups. "We talk to them about strengths and weaknesses and where we would like – these are the things we really need to work on, so we can add that into your game and into the repertoire of your actual game day and how you play." said Reid "You have to practice those things and do it fast and make it to where it's just second nature for you. So yeah, we talk about those types of things. Then, obviously, I think everybody right now is sitting there going, 'Yeah, you want to win the Super Bowl. That's what you want to do.' We're right there; that's our primary goal, to put ourselves in the best position we can to win." Caliendo was an undrafted free agent signed out of Western Michigan by the Chiefs in 2022. The comparison to former Chiefs offensive lineman and current Commanders starter Nick Allegretti is a hopeful one to build on as the team heads into training camp.
Yahoo
28-05-2025
- Business
- Yahoo
UBS Sees Misunderstood Strength in Lifestance Health Group (LFST), Upgrades to Buy
UBS analyst Kevin Caliendo raised the rating of LifeStance Health Group, Inc. (NASDAQ:LFST) from Neutral to Buy on May 27, with an unchanged price target of $8.50. Caliendo ascribes the boost to investor de-risking and possible misunderstandings of recent corporate developments, which followed a period of downturn for the LFST stock. Despite a cautious forecast for the second quarter, LifeStance Health Group, Inc. (NASDAQ:LFST) reported a robust first quarter, exceeding projections, with adjusted EBITDA increasing 25% to $35 million and revenue rising 11% year-over-year to $333 million. In addition, Caliendo discussed the company's decision to switch from stock to cash incentives, which he views as an effective strategy that could yield LifeStance Health Group, Inc. (NASDAQ:LFST) over $40 million in net income yearly for the next four years. The analyst also brushed aside worries about the federal government's decision to suspend the mental health parity rule. He added that the company's reimbursement rates and rate-improvement track shouldn't be impacted by this suspension. LifeStance Health Group, Inc. (NASDAQ:LFST) is an American outpatient behavioral health service company that offers in-person and telehealth services. The company offers therapy, psychiatry, and TMS. While we acknowledge the potential of LFST to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LFST and that has 100x upside potential, check out our report about the cheapest AI stock. Read More: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
25-03-2025
- Sport
- USA Today
Kansas City Chiefs officially re-sign OL Mike Caliendo
Kansas City Chiefs officially re-sign OL Mike Caliendo The offensive line will retain a starter from last season who stepped up after the lineup was shuffled. The Kansas City Chiefs are exercising their options to keep a valued restricted free agent. According to multiple reports, the Chiefs have officially re-signed exclusive rights free agent offensive guard Mike Caliendo after the right of first refusal tender. The veteran offensive lineman will earn a $3.263 million salary for the 2025 NFL season. Caliendo started at left guard over the last month of the regular season and postseason after the coaching staff moved All-Pro Joe Thuney to left tackle. Since going undrafted in 2022, he has spent his NFL career primarily on the Chiefs practice squad. He was a standout at Western Michigan, named first-team all-conference, and a finalist for the William V. Campbell Trophy. Kansas City added Jaylon Moore in free agency to likely be the consistent starter at left tackle as the unit seeks redemption after a disappointing performance in Super Bowl LIX.
USA Today
26-01-2025
- Sport
- USA Today
Is Mike Caliendo playing today? Injury updates for Chiefs OL
Set to face the Buffalo Bills today in the AFC Championship Game, the Kansas City Chiefs will rely on their most experienced offensive linemen to keep star quarterback Patrick Mahomes on passing plays. Veteran guard Mike Caliendo was listed on the Chiefs' injury report this week, which threatened to throw Kansas City's front-five in disarray. Is Caliendo expected to play against the Bills in the AFC Championship Game? Mike Caliendo injury update Caliendo is dealing with a shoulder injury, but it did not keep him from fully participating in all of the Chiefs' practices this week. How long will Mike Caliendo be out? Caliendo is not expected to miss any time due to his condition and will take the field for Kansas City in the AFC Championship Game. Chiefs LG depth chart Caliendo is filling in for veteran left guard Joe Thuney, who is currently manning the left tackle position. It is unclear who would take Caliendo's place if he is forced to leave the field against Buffalo.
